| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
Tafazzin |
| Specificity: |
This antibody reacts specifically with Tafazzin |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
KLH conjugated synthetic peptide derived from human Tafazzin |
| Gene ID: |
6901 |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Human (Homo sapiens) |
| Cross Reactive Species details: |
However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species |
| Background information: |
A long form and a short form of each of these isoforms is produced, Multiple transcript variants encoding different isoforms have been described, Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known, and left ventricular noncompaction (LVNC), dilated cardiomyopathy (DCM), endocardial fibroelastosis, hypertrophic DCM, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound, This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
BTHS XAP-2 G4, 5 TAZ1 |
| Also known as: |
Tafazzin Polyclonal Antibody |
| Other name: |
Anti-Tafazzin Polyclonal |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Group: |
Polyclonals and antibodies |
| About: |
The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target: |
Tafazzin |
| Short name: |
Anti-Tafazzin (Polyclonal) Fluor 594 |
| Technique: |
Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-Tafazzin (polyclonal) |
| Alternative technique: |
polyclonals |
| Identity: |
11577 |
| Gene: |
TAZ |
More about : TAZ |
| Long gene name: |
tafazzin |
| Synonyms gene: |
CMD3A EFE2 EFE |
| Synonyms gene name: |
dilated 3A (X-linked) , endocardial fibroelastosis 2 cardiomyopathy |
| Synonyms name: |
Barth syndrome |
| Locus: |
Xq28 |
| Discovery year: |
1989-05-29 |
| GenBank acession: |
X92762 |
| Entrez gene record: |
6901 |
| Pubmed identfication: |
8042670 |
| Havana BLAST/BLAT: |
OTTHUMG00000033190 |
| Locus Specific Databases: |
TAZbase: Mutation registry for Barth syndrome LRG_131 |